Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001731122-22-000960)

Filing Details

Accession Number:: 0001731122-22-000960
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-05-20 21:37:22
Reporting Period:: 2022-05-18

Accepted Time:: 2022-05-20 21:37:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1527728	Enochian Biosciences Inc	ENOB	Pharmaceutical Preparations (2834)	452259340

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1813678	Serhat Gumrukcu	C/O Enochian Biosciences Inc. 2080 Century City East, Suite 906 Los Angeles CA 90067		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-05-18	125,000	$8.00	12,401,552	No	4	S	Direct
Common Stock	Disposition	2022-05-18	128,493	$8.00	12,273,059	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,712,789	Indirect	By Spouse

Footnotes

The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.